Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Allez

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Gut|March 13, 2012
The multiple effects of tumour necrosis factor inhibitors on immune cells: new insights on inhibition of activation and cyclingMatthieu Allez
Gastroenterology|August 5, 2022
A CEACAM5-derived Peptide Activating CD8<sup>+</sup> Regulatory T Cells: A Future Option for Restoring Mucosal Homeostasis in Crohn's Disease?Matthieu Allez
La Revue Du Praticien|February 24, 2005
[Crohn's disease and ulcerative colitis]Marc Lémann, Matthieu Allez
La Revue Du Praticien|August 2, 2005
[Treatment strategies for inflammatory bowel disease]Marc Lémann, Matthieu Allez
The American Journal of Gastroenterology|September 7, 2017
Response to Dhoble et alMathurin Fumery, Matthieu Allez
World Journal of Gastroenterology|June 3, 2010
Role of endoscopy in predicting the disease course in inflammatory bowel diseaseMatthieu Allez, Marc Lémann
Current Drug Targets|March 10, 2010
Efficacy of anti-TNF in Crohn's disease: how does it work?Yehuda Chowers, Matthieu Allez
Alimentary Pharmacology & Therapeutics|March 13, 2023
Editorial: severe colitis induced by targeted therapies in dermato-oncology beyond check point-inhibitorsNassim Hammoudi, Matthieu Allez
The Lancet. Gastroenterology & Hepatology|February 15, 2025
Vedolizumab for prevention of recurrence of Crohn's diseaseNassim Hammoudi, Matthieu Allez
Current Opinion in Gastroenterology|June 4, 2015
Complications of biologics in inflammatory bowel diseasePaula Sousa, Matthieu Allez
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Gut|March 13, 2012
The multiple effects of tumour necrosis factor inhibitors on immune cells: new insights on inhibition of activation and cyclingMatthieu Allez
Gastroenterology|August 5, 2022
A CEACAM5-derived Peptide Activating CD8<sup>+</sup> Regulatory T Cells: A Future Option for Restoring Mucosal Homeostasis in Crohn's Disease?Matthieu Allez
La Revue Du Praticien|February 24, 2005
[Crohn's disease and ulcerative colitis]Marc Lémann, Matthieu Allez
La Revue Du Praticien|August 2, 2005
[Treatment strategies for inflammatory bowel disease]Marc Lémann, Matthieu Allez
The American Journal of Gastroenterology|September 7, 2017
Response to Dhoble et alMathurin Fumery, Matthieu Allez
World Journal of Gastroenterology|June 3, 2010
Role of endoscopy in predicting the disease course in inflammatory bowel diseaseMatthieu Allez, Marc Lémann
Current Drug Targets|March 10, 2010
Efficacy of anti-TNF in Crohn's disease: how does it work?Yehuda Chowers, Matthieu Allez
Alimentary Pharmacology & Therapeutics|March 13, 2023
Editorial: severe colitis induced by targeted therapies in dermato-oncology beyond check point-inhibitorsNassim Hammoudi, Matthieu Allez
The Lancet. Gastroenterology & Hepatology|February 15, 2025
Vedolizumab for prevention of recurrence of Crohn's diseaseNassim Hammoudi, Matthieu Allez
Current Opinion in Gastroenterology|June 4, 2015
Complications of biologics in inflammatory bowel diseasePaula Sousa, Matthieu Allez
Pageof 21